VIAGETX.COM: Keyword Density Checker

Total words: 3305 | 2-word phrases: 870 | 3-word phrases: 960 | 4-word phrases: 983

PAGE INFO

Title	Try to keep the title under 60 characters (18 characters) Viage Therapeutics
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (5 characters) About

#	Keyword	Frequency	Density
1	in the gut	4	0.42%
2	company developing firstinclass	3	0.31%
3	a biotech company	3	0.31%
4	biotech company developing	3	0.31%
5	cns via the	2	0.21%
6	gutbrainaxis announced today	2	0.21%
7	announced today the	2	0.21%
8	cells in the	2	0.21%
9	enteroendocrine cells in	2	0.21%
10	on enteroendocrine cells	2	0.21%
11	zhongze therapeutics digestome	2	0.21%
12	today the completion	2	0.21%
13	the completion of	2	0.21%
14	specific receptor interactions	2	0.21%
15	the vagus nerve	2	0.21%
16	via the gutbrainaxis	2	0.21%
17	terms on the	2	0.21%
18	a firstinclass oral	2	0.21%
19	therapeutics digestome therapeutics	2	0.21%
20	phase 1 study	2	0.21%
21	head of dmpk	2	0.21%
22	drug development experience	2	0.21%
23	dgx001 a firstin	2	0.21%
24	the drug candidate	2	0.21%
25	2022 digestome therapeutics	2	0.21%
26	therapeutics a biotech	2	0.21%
27	developing firstinclass therapeutics	2	0.21%
28	therapeutics that stimulate	2	0.21%
29	that stimulate the	2	0.21%
30	stimulate the central	2	0.21%

#	Keyword	Frequency	Density
1	biotech company developing firstinclass	3	0.31%
2	a biotech company developing	3	0.31%
3	the central nervous system	2	0.20%
4	cells in the gut	2	0.20%
5	company developing firstinclass therapeutics	2	0.20%
6	system cns via the	2	0.20%
7	zhongze therapeutics digestome therapeutics	2	0.20%
8	nervous system cns via	2	0.20%
9	central nervous system cns	2	0.20%
10	on enteroendocrine cells in	2	0.20%
11	a platform of novel	2	0.20%
12	on a platform of	2	0.20%
13	based on a platform	2	0.20%
14	company based on a	2	0.20%
15	neuroscience company based on	2	0.20%
16	enteroendocrine cells in the	2	0.20%
17	therapeutics a biotech company	2	0.20%
18	the completion of a	2	0.20%
19	that stimulate the central	2	0.20%
20	today the completion of	2	0.20%
21	gutbrainaxis announced today the	2	0.20%
22	announced today the completion	2	0.20%
23	stimulate the central nervous	2	0.20%
24	20 years as public	1	0.10%
25	board member led formation	1	0.10%
26	member led formation of	1	0.10%
27	to main about team	1	0.10%
28	ceo and board member	1	0.10%
29	and board member led	1	0.10%
30	cmc 20 years as	1	0.10%
31	of pnh steven king	1	0.10%
32	company ceo and board	1	0.10%
33	public company ceo and	1	0.10%
34	as public company ceo	1	0.10%
35	years as public company	1	0.10%
36	pnh steven king msc	1	0.10%
37	skip to main about	1	0.10%
38	treatment of pnh steven	1	0.10%
39	and bachem americas significant	1	0.10%
40	and commercialization former vp	1	0.10%

#	URL	Whois	Check
1	https://linkedin.com/in/titus-plattel-b4200b1	Whois	linkedin.com
2	https://linkedin.com/in/stevesmith1202	Whois	linkedin.com
3	https://www.linkedin.com/in/brian-rogers-43a23a/	Whois	linkedin.com
4	https://linkedin.com/in/dirkesmith	Whois	linkedin.com
5	https://linkedin.com/in/neil-schwartz-b189ba94	Whois	linkedin.com
6	https://linkedin.com/in/najib-maslouh	Whois	linkedin.com
7	https://linkedin.com/in/steven-king-06305328	Whois	linkedin.com
8	https://linkedin.com/in/taka-koda-027a089	Whois	linkedin.com
9	https://www.popularmechanics.com/science/health/a34934637/gut-brain-science/	Whois	popularmechanics.com